News

Keeping you current on new and follow-on investments, portfolio product and service milestones, publications and events, management and board transitions, and other developments in Tullis funds.

July

17

ElectroCore and UpScript Launch Program to Offfer Direct-To-Patient Telemedicine Option For GammaCore™ in the United States

gammaCore is the first FDA-cleared, nVNS therapy that can be self-administered by patients as...

13

New Research Shows Promise in Regional Deliver of CAR-T Therapy

Authors conclude delivery devices should be developed in conjunction with CAR-T therapies DENVER–(BUSINESS WIRE)–Surefire...

11

OrthoSensor Secures Aditional 510(k) Clearance

VERASENSE™ Sensor-Assisted Technology Now Approved for Use with Zimmer Biomet Persona® Knee System, enabling surgeons...

8

Alphatec Spine Disrupts Market With Acquisition Of Safeop Surgical

CARLSBAD, CA — March 8, 2018 — Alphatec Holdings, Inc. (“Alphatec” or the “Company”) (Nasdaq:...

25

Exagen Diagnostics Announces Collaboration With GSK To Drive Greater Awareness About Challenges Facing Lupus Diagnosis And Management

ALBUQUERQUE, NM and SAN DIEGO, CA — January 25, 2018 — Exagen Diagnostics, Inc....

23

Surefire Medical Appoints Mary T. Szela CEO And President

DENVER, Jan. 23, 2018 – Surefire Medical, Inc. (Surefire) today announced the appointment of Mary...

Recent developments

July

17

ElectroCore and UpScript Launch Program to Offfer Direct-To-Patient Telemedicine Option For GammaCore™ in the United States

July

13

New Research Shows Promise in Regional Deliver of CAR-T Therapy

June

11

OrthoSensor Secures Aditional 510(k) Clearance

March

8

Alphatec Spine Disrupts Market With Acquisition Of Safeop Surgical

January

25

Exagen Diagnostics Announces Collaboration With GSK To Drive Greater Awareness About Challenges Facing Lupus Diagnosis And Management

January

23

Surefire Medical Appoints Mary T. Szela CEO And President